Pliant Therapeutics, Inc.
PLRX
$1.15
$0.021.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 55.41% | 48.42% | 28.99% | 12.98% | -11.63% |
| Total Depreciation and Amortization | -30.29% | -26.60% | -20.19% | -16.05% | -7.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -37.89% | -31.60% | -19.12% | -22.88% | -9.97% |
| Change in Net Operating Assets | -2.95% | -13,681.97% | -275.37% | -223.50% | -527.75% |
| Cash from Operations | 58.15% | 43.31% | 17.47% | -19.01% | -23.75% |
| Capital Expenditure | 100.00% | 95.72% | 90.28% | 84.24% | 48.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -76.84% | -60.05% | -6.71% | 25.76% | 22.92% |
| Cash from Investing | -76.49% | -59.26% | -4.31% | 28.94% | 24.41% |
| Total Debt Issued | -- | -- | -- | -99.99% | -99.99% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -87.22% | -92.00% | -82.23% | -79.90% | -68.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2,910.24% | -1,858.13% | -237.12% | -97.11% | -95.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,062.65% | -211.91% | -423.65% | -39.73% | -76.10% |